AzTrials
AzTrials

Lumbal Disc HerniationLDH-TECARNCT07082660

Tecar Therapy in Lumbar Disc Herniation

A study testing High-Frequency Capacitive-Resistive Diathermic Current Therapy (TECAR) and Lumbal Stabilization Exercise Program in people with Lumbal Disc Herniation and Capacitive and Resistive Electric Transfer Therapy, run by Şebnem Nur Alkan at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial investigates the effects of Tecar therapy on pain intensity and functional status in patients with lumbar disc herniation. The intervention group received Tecar therapy combined with conventional physiotherapy, while the control group received only conventional physiotherapy. Read more about this study

Who is it for?
Ages 20 to 60 years
What is being tested?
High-Frequency Capacitive-Resistive Diathermic Current Therapy (TECAR) and Lumbal Stabilization Exercise Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2023to 20 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • aged 20-60 years
  • diagnosed with low back pain
  • pain localized between L1 and L5
  • having low back pain lasting for more than 3 months [24].

Who cannot join

  • having sensory disturbances
  • muscle weakness, or reflex loss identified during motor, sensory, or reflex examinations
  • history of prior lumbal spine surgery or vertebral fractures
  • presence of electronic medical devices such as pacemakers or other implants contraindicated for electrical stimulation or high-frequency diathermy therapy
  • patients officially registered as disabled or receiving social benefits due to low back pain, severe osteoporosis, osteomalacia, malignancy, infectious diseases, or systemic musculoskeletal or rheumatological disorders,
  • pregnancy,
  • cardiovascular conditions preventing exercise, or viscerogenic causes of low back pain

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Atlas University

    Istanbul, Kagıthane, 34403

Other trials in Turkey (Türkiye)

About this study

Official title: A Randomized Controlled Trial On Lumbal Disc Herniation Using Tecar Therapy: Effects On Pain And Functionality

This randomized controlled trial investigates the effects of Tecar therapy on pain intensity and functional status in patients with lumbar disc herniation. The intervention group received Tecar therapy combined with conventional physiotherapy, while the control group received only conventional physiotherapy. Outcome measures include pain intensity, lumbar mobility, and functional disability. The study aims to determine whether Tecar therapy provides additional benefits compared to standard care in the early rehabilitation of individuals with lumbar disc herniation.

Read the detailed description

Background Lumbar disc herniation (LDH) is a prevalent musculoskeletal condition that can significantly impair quality of life due to pain and functional limitations. Rehabilitation strategies often include lumbar stabilization exercises, and adjunct electrotherapies such as capacitive-resistive diathermy (TECAR) have gained interest for their potential therapeutic effects.

Purpose This randomized controlled trial aims to evaluate the effects of adding high-frequency capacitive-resistive diathermic current (TECAR) therapy to lumbar stabilization exercises, compared to lumbar stabilization exercises alone, on pain intensity, functional status, and lumbar range of motion in individuals with chronic LDH.

Methods

Thirty participants with chronic LDH (duration >6 months) and no neurological deficits will be randomly assigned to one of two intervention groups:

TECAR + Exercise Group (TEG, n=15): Participants will receive 12 sessions of TECAR therapy (20 minutes, 3 sessions per week) in combination with lumbar stabilization exercises over 4 weeks.

Exercise Group (EG, n=15): Participants will receive only lumbar stabilization exercises with the same frequency and duration.

Outcome measures will include:

Pain intensity (Visual Analog Scale - VAS)

Functional status (Oswestry Disability Index - ODI)

Lumbar range of motion (goniometry)

All evaluations will be performed pre- and post-intervention by a physiotherapist who is blinded to group allocation.

Being tested
High-Frequency Capacitive-Resistive Diathermic Current Therapy (TECAR), Lumbal Stabilization Exercise Program
Keywords
Lumbal disk herniation, Capasitive and resistive electric transfer therapy, exercise training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-Frequency Capacitive-Resistive Diathermic Current Therapy (TECAR)Device

    20 minutes per session, 3 times per week for 4 weeks

  • Lumbal Stabilization Exercise ProgramBehavioural

    3 sessions per week for 4 weeks, each session includes core stabilization and lumbar control exercises (12 sessions total).

Study groups in NCT07082660
Study groupRoleWhat they receive
TECAR Therapy Combined with Lumbal Stabilization ExercisesExperimentalParticipants in this group will receive high-frequency capacitive-resistive diathermic current (TECAR) therapy (20 minutes per session, 3 sessions/week for 4 weeks) in addition to a lumbal stabilization exercise program (12 sessions total).
Receives: Device: High-Frequency Capacitive-Resistive Diathermic Current Therapy (TECAR)
Lumbal Stabilization Exercises OnlyActive comparatorParticipants in this group will receive only the lumbal stabilization exercise program, 3 sessions/week for 4 weeks (12 sessions total), with no TECAR therapy applied.
Receives: Behavioral: Lumbal Stabilization Exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lumbar functionality

    The Oswestry Disability Index (ODI), validated Turkish version, will be used to assess disability related to low back pain. The scale consists of 10 items, each scored from 0 to 5, with a total maximum score of 50. The total score is converted into a percentage using the formula: (total obtained score / maximum possible score) × 100. Scores range from 0% to 100%, where higher scores indicate greater disability. Interpretation categories are as follows: 0%-20% indicates minimal disability; 21%-40% indicates moderate disability; 41%-60% indicates severe disability; 61%-80% indicates crippled; and 81%-100% indicates bed-bound status or possible symptom exaggeration.

    Measured: Baseline - 4 weeks

Secondary outcomes (1)
  1. Pain intensity

    The Visual Analog Scale (VAS) will be used to assess pain intensity. It consists of a 10-centimeter horizontal line representing a continuum from 'no pain' (0) to 'worst imaginable pain' (10). Participants are asked to mark a point on the line that corresponds to the intensity of their pain. The distance in centimeters from the 'no pain' anchor to the participant's mark is measured and recorded as the VAS score. Scores range from 0 to 10, with higher scores indicating greater pain severity.

    Measured: Baseline - 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2025
  2. Study start1 Jan 2023
  3. Primary completion30 Mar 2023
  4. Study completion20 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned to two parallel groups receiving either TECAR + lumbar stabilization or lumbar stabilization only.
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07082660
Sponsor's protocol ID
ETTBI-LDH-2023-01
Acronym
LDH-TECAR
Status last verified
Jul 2025
First submitted
15 Jul 2025
Last updated
24 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data (IPD) that underlie the results reported in the article (after deidentification) will be shared with other researchers upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing High-Frequency Capacitive-Resistive Diathermic Current Therapy (TECAR) and Lumbal Stabilization Exercise Program in people with Lumbal Disc Herniation and Capacitive and Resistive Electric Transfer Therapy, run by Şebnem Nur Alkan at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lumbar functionality (time frame: Baseline - 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in